From today’s PR: Didn’t we think this was in
Post# of 36537
(Total Views: 335)
Posted On: 07/01/2020 9:26:41 AM
From today’s PR: Didn’t we think this was in process already?
Also, we are poised to begin testing Ii-Key-SARS-CoV-2 peptides against blood samples from patients who have recovered from COVID-19 to select those peptides that activate a T-Cell response and can generate neutralizing antibodies to be included in a final vaccine formulation for clinical trials, which we hope to start in the Fall.
Read More: https://investorshangout.com/post/view?id=581...z6QwvDNLXH
Also, we are poised to begin testing Ii-Key-SARS-CoV-2 peptides against blood samples from patients who have recovered from COVID-19 to select those peptides that activate a T-Cell response and can generate neutralizing antibodies to be included in a final vaccine formulation for clinical trials, which we hope to start in the Fall.
Read More: https://investorshangout.com/post/view?id=581...z6QwvDNLXH
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼